MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./320/0.1/20.12.24 Share Price

Warrant

DE000MG03862

Real-time Bid/Ask 05:09:11 18/06/2024 pm IST
0.18 EUR / 0.28 EUR +4.55% Intraday chart for MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./320/0.1/20.12.24
Current month+147.19%
1 month+120.00%
Date Price Change
18/24/18 0.18 -18.18%
17/24/17 0.22 +2.80%
14/24/14 0.214 +2.88%
13/24/13 0.208 +30.00%
12/24/12 0.16 +9.59%

Delayed Quote Börse Stuttgart

Last update June 18, 2024 at 11:40 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG0386
ISINDE000MG03862
Date issued 12/03/2024
Strike 320 $
Maturity 20/12/2024 (186 Days)
Parity 10 : 1
Emission price 0.17
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.26
Lowest since issue 0.071
Spread 0.1
Spread %37.04%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232.8 USD
Average target price
279.2 USD
Spread / Average Target
+19.95%
Consensus